Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and Granulomatous Disease, Chronic

phenylmethylsulfonyl fluoride has been researched along with Granulomatous Disease, Chronic in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

Granulomatous Disease, Chronic: A defect of leukocyte function in which phagocytic cells ingest but fail to digest bacteria, resulting in recurring bacterial infections with granuloma formation. When chronic granulomatous disease is caused by mutations in the CYBB gene, the condition is inherited in an X-linked recessive pattern. When chronic granulomatous disease is caused by CYBA, NCF1, NCF2, or NCF4 gene mutations, the condition is inherited in an autosomal recessive pattern.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colotta, F1
Bersani, L1
Lazzarin, A1
Poli, G1
Mantovani, A1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and Granulomatous Disease, Chronic

ArticleYear
Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors.
    Journal of immunology (Baltimore, Md. : 1950), 1985, Volume: 134, Issue:5

    Topics: Adolescent; Adult; Animals; Catalase; Cell Line; Cytotoxicity, Immunologic; Dactinomycin; Female; Fr

1985